Ben Tre Pharmaceutical JSC (HOSE:DBT)

Market Cap	247.13B +6.5%
Revenue (ttm)	860.31B -0.9%
Net Income	12.85B -2.6%
EPS	614.00 -13.1%
Shares Out	21.97M
PE Ratio	18.32
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	500
Open	10,800
Previous Close	10,750
Day's Range	10,750 - 11,250
52-Week Range	9,990 - 12,600
Beta	0.43
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 29, 2026

About HOSE:DBT

Ben Tre Pharmaceutical Joint Stock Company manufactures, distributes, and sells pharmaceutical products in Vietnam and internationally. The company offers drugs in injectable, infusion, pill, and lotion forms. The company provides products covering various therapeutic areas, including central nervous system, respiratory system, endocrinology, obstetrics and gynecology, anti-allergic, cardiovascular, antibiotics, anti-fungal, anti-viral, musculoskeletal, vitamins and minerals, digestive, hepatobiliary and urinary, pain relief, fever reducer, ant...

• Industry: Pharmaceutical Preparations
• Founded: 1963
• Employees: 683
• Stock Exchange: Ho Chi Minh Stock Exchange
• Ticker Symbol: DBT

Financial Performance

In 2025, HOSE:DBT's revenue was 860.31 billion, a decrease of -0.93% compared to the previous year's 868.41 billion. Earnings were 12.85 billion, a decrease of -2.66%.